NADLT Supplier in India: A Complete Sourcing Guide

23-07-2026

Quick answer: NADLT (N-Acetyl-DL-Tryptophan, CAS 87-32-1) is a specialty pharmaceutical excipient used primarily as a stabilizer in blood-derived and biopharmaceutical products, most notably human serum albumin. Buyers sourcing it in India should confirm low microbial and endotoxin limits, batch-specific documentation, and since it lacks an established NF monograph clarity on which analytical method the supplier tests against.

Formulators and procurement teams searching for an NADLT supplier in India are almost always working on a narrower problem than general excipient sourcing: NADLT isn't a broad-use filler or binder, it's a specialty stabilizer with a specific, well-documented role in biopharmaceutical manufacturing. That narrower use case changes what "the right supplier" actually looks like.

What is NADLT?

NADLT stands for N-Acetyl-DL-Tryptophan, a chemically synthesized derivative of the amino acid tryptophan. It's most widely recognized as a stabilizer used in blood-derived therapeutics particularly human serum albumin where it protects the protein during the heat treatment step used for viral inactivation. Because albumin formulations are used in critically ill patients (for conditions like hypovolemia, shock, burns, and liver disease), the quality bar for any excipient added to these products is unusually high.

This is why NADLT sourced for pharmaceutical or biopharma use is typically requested with low microbial and endotoxin limits specifically called out a stricter requirement than many general-purpose excipients carry, and one directly tied to its role in injectable, blood-derived products.

Where NADLT sits in the excipient landscape

Unlike broadly used excipients fillers, binders, or lubricants that appear across thousands of formulations NADLT occupies a narrow, specialized niche. Its primary buyers are:

Manufacturers of human serum albumin and other plasma-derived therapeutics
Biopharmaceutical companies formulating heat-treated or pasteurized protein products
Analytical and QC labs needing NADLT as a reference standard or impurity marker (it's also used in method validation contexts, including as a documented impurity reference in unrelated drug substance testing)

Because the buyer pool is narrower and more specialized than for general excipients, sourcing NADLT in India often means working with suppliers who specifically stock biopharma-grade specialty excipients, rather than general excipient distributors whose catalogue is built around high-volume, broad-application materials.

What to look for in a supplier

Documented microbial and endotoxin limits. Since NADLT is used in injectable, blood-derived products, suppliers should be able to provide test data on bioburden and endotoxin content as a standard part of their documentation not as a special request.

Batch-specific Certificate of Analysis (CoA). As with any specialty excipient, request the CoA for the actual lot you're purchasing, not a generic reference document.

Clarity on monograph status. NADLT does not currently have an established NF (National Formulary) monograph a monograph has been proposed based on validated HPLC methods, but it isn't yet an established compendial standard the way many common excipients are. This means suppliers may test against their own internal specification or a proposed method rather than a finalized pharmacopoeial monograph. Ask explicitly which analytical method and acceptance criteria your supplier tests against.

Experience with biopharma-grade material. Given its specific end use, a supplier's track record supplying NADLT for albumin or plasma-product manufacturing is a stronger signal of reliability than general excipient distribution experience alone.

Regulatory documentation support. For manufacturers filing biologics license applications or equivalent regulatory submissions, ask whether the supplier can support DMF-style documentation or equivalent regulatory dossiers referencing the raw material source.

Why sourcing channel matters for a specialty excipient like NADLT

Because NADLT has a narrower, more technical buyer base than commodity excipients, traditional sourcing has often meant going directly to a small number of specialty distributors sometimes international ones rather than a broad domestic supplier network. This can mean longer lead times and less price transparency than sourcing a widely available excipient.

Digital procurement platforms that specialize in pharmaceutical raw materials are starting to change this by listing specialty and rare excipients alongside common ones, with documentation and instant quoting handled the same way regardless of how niche the compound is. For a specialty stabilizer like NADLT, this matters more than it would for a commodity excipient, since the traditional sourcing path has historically been slower and less transparent precisely because demand is smaller and more specialized.

Sourcing checklist before you order

Confirm the supplier tests for microbial limits and endotoxin content, not just chemical purity
Request the batch-specific CoA and ask which analytical method (compendial or internal) was used
Clarify whether the material is intended for biopharma/injectable use versus general research use
Ask about experience supplying NADLT specifically for albumin or plasma-product stabilization
Confirm lead time specialty excipients can carry longer lead times than commodity ones, so build this into your project timeline
Ask whether regulatory support documentation is available if you're filing a biologics application

Frequently asked questions

Is NADLT the same as N-Acetyl-L-Tryptophan?

No. NADLT refers specifically to the DL (racemic) form a mixture of the D- and L-enantiomers of N-acetyltryptophan. Research on albumin stabilization has found the D- and L-enantiomers to be equally effective as stabilizers, which is part of why the racemic DL form is the one commonly used industrially, rather than requiring an enantiomerically pure L-form.

Does NADLT have a USP or EP monograph?

As of current pharmacopoeial status, NADLT does not have an established NF monograph; a new monograph has been proposed based on validated HPLC methods, but buyers should confirm current status with their supplier and cross-check the latest USP-NF or Pharmacopeial Forum listings, since compendial status can change.

Is NADLT used only in albumin manufacturing?

Its most documented and well-established use is as a heat-treatment stabilizer in human serum albumin, though it also appears in some analytical reference and impurity-standard contexts. Buyers should confirm the specific application before assuming interchangeability across use cases.

The bottom line

NADLT is a narrower, more specialized sourcing problem than general excipients the buyer pool is smaller, the quality requirements (microbial, endotoxin) are stricter given its use in blood-derived injectables, and its compendial status is still evolving. A supplier who can speak specifically to its biopharma stabilizer use case, rather than treating it as a generic amino acid derivative, is generally the more reliable choice.

Sourcing NADLT for a biopharma formulation project? Explore N-Acetyl-DL-Tryptophan on Clyzo and request documentation and a quote directly.

Vaccine Excipients Oral Topical Biopharma

Ethanol 96% v/v for pharmaceutical excipients (Ph.... ... Ethanol 96% v/v for pharmaceutical excipients (Ph.Eur., BP, USP IPEC Grade) | Clyzo Read more

14-08-2026